Between Scylla and Charibdis: EIF2α kinases as targets for cancer chemotherapy

Clinical and Translational Oncology

Volumn 13, Issue 7, 2011, Pages 442-445

  Moreno Torres, Marta ^a   Murguía, José R ^a  

^a Universitat Politècnica de València   (Spain)

Author keywords

eIF2 alpha phosphorylation; GCN2; PERK; PKR; Translation

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; ANTINEOPLASTIC AGENT; ASPARAGINE; ASPARAGINE SYNTHASE; INITIATION FACTOR 2ALPHA; SYNTHETASE; TIRAPAZAMINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GCN2; UNCLASSIFIED DRUG; INITIATION FACTOR 2;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL CYCLE REGULATION; CELL HYPOXIA; CELLULAR STRESS RESPONSE; CHEMOSENSITIVITY; CHEMOTHERAPY RESISTANCE; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG RESISTANCE; ENZYME PHOSPHORYLATION; NONHUMAN; PROTEIN FUNCTION; PROTEIN TARGETING; TUMOR PROMOTION; DRUG ANTAGONISM; GENETICS; HUMAN; METABOLISM; NEOPLASM;

ANTINEOPLASTIC AGENTS; EUKARYOTIC INITIATION FACTOR-2; HUMANS; NEOPLASMS;

EID: 82255174098     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-011-0680-3     Document Type: Article

References (29)

1. Sonenberg N, Hinnebusch AG (2007) New modes of translational control in development, behavior, and disease. Mol Cell 28:721-729 (Pubitemid 350217066)
2. Hinnebusch AG (2005) Translational regulation of GCN4 and the general amino acid control of yeast. Annu Rev Microbiol 59:407-450 (Pubitemid 41507438)
3. Dever TE, Dar AC, Sicheri F (2007) The eIF2alpha kinases. In: Mathews MB, Sonenberg N, Hershey JWB (eds) Translational control in biology and medicine. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, p 319-345
4. Wang L, Liu Y, Wu S (2010) The roles of nitric oxide synthase and eIF2alpha kinases in regulation of cell cycle upon UVB-irradiation. Cell Cycle 9:38-42
5. Bouffant RL, Boulben S, Cormier P et al (2008) Inhibition of translation and modification of translation factors during apoptosis induced by the DNA-damaging agent MMS in sea urchin embryos. Exp Cell Res 314:961-968
6. Tvegard T, Soltani H, Skjolberg HC et al (2007) A novel checkpoint mechanism regulating the G1/S transition. Genes Dev 21:649-654 (Pubitemid 46440287)
7. Menacho-Marquez M, Perez-Valle J, Arino J et al (2007) Gcn2p regulates a G1/S cell cycle checkpoint in response to DNA damage. Cell Cycle 6:2302-2305 (Pubitemid 47547709)
8. Hamanaka RB, Bennett BS, Cullinan SB, Diehl JA (2005) PERK and GCN2 contribute to eIF2alpha phosphorylation and cell cycle arrest after activation of the unfolded protein response pathway. Mol Biol Cell 16:5493-5501 (Pubitemid 41752201)
9. Brewer JW, Diehl JA (2000) PERK mediates cellcycle exit during the mammalian unfolded protein response. Proc Natl Acad Sci U S A 97:12625-12630
10. Raven JF, Baltzis D, Wang S et al (2008) PKR and PKR-like endoplasmic reticulum kinase induce the proteasome-dependent degradation of cyclin D1 via a mechanism requiring eukaryotic initiation factor 2alpha phosphorylation. J Biol Chem 283:3097-3108
11. Deng J, Harding HP, Raught B et al (2002) Activation of GCN2 in UV-irradiated cells inhibits translation. Curr Biol 12:1279-1286 (Pubitemid 34869877)
12. Jiang HY, Wek RC (2005) GCN2 phosphorylation of eIF2alpha activates NF-kappaB in response to UV irradiation. Biochem J 385:371-380 (Pubitemid 40165069)
13. Rodriguez PC, Quiceno DG, Ochoa AC (2007) L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 109:1568-1573 (Pubitemid 46239590)
14. Munn DH, Sharma MD, Baban B et al (2005) GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22:633-642 (Pubitemid 40719198)
15. Usui T, Nagumo Y, Watanabe A et al (2006) Brasilicardin A, a natural immunosuppressant, targets amino acid transport system L. Chem Biol 13:1153-1160 (Pubitemid 44750728)
16. Peidis P, Papadakis AI, Rajesh K, Koromilas AE (2010) HDAC pharmacological inhibition promotes cell death through the eIF2alpha kinases PKR and GCN2. Aging 2:669-677
17. Peidis P, Papadakis AI, Muaddi H et al (2010) Doxorubicin bypasses the cytoprotective effects of eIF2alpha phosphorylation and promotes PKRmediated cell death. Cell Death Differ 18:145-154
18. Lou JJ, Chua YL, Chew EH et al (2010) Inhibition of hypoxia-inducible factor-1alpha (HIF-1alpha) protein synthesis by DNA damage inducing agents. PloS one 5:e10522
19. Boyce M, Bryant KF, Jousse C et al (2005) A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 307:935-939 (Pubitemid 40229232)
20. Schewe DM, Aguirre-Ghiso JA (2009) Inhibition of eIF2alpha dephosphorylation maximizes bortezomib efficiency and eliminates quiescent multiple myeloma cells surviving proteasome inhibitor therapy. Cancer Res 69:1545-1552
21. Suzuki M, Endo M, Shinohara F et al (2009) Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells. Cancer Chemother Pharmacol 64:1115-1122
22. Sequeira SJ, Wen HC, Avivar-Valderas A et al (2009) Inhibition of eIF2alpha dephosphorylation inhibits ErbB2-induced deregulation of mammary acinar morphogenesis. BMC Cell Biol 10:64
23. Monti E, Gariboldi MB (2011) HIF-1 as a target for cancer chemotherapy, chemosensitization and chemoprevention. Curr Mol Pharmacol 4:62-77
24. Zhang J, Cao J, Weng Q et al (2010) Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) by tirapazamine is dependent on eIF2alpha phosphorylation rather than the mTORC1/4E-BP1 pathway. PloS One 5:e13910
25. Ye J, Kumanova M, Hart LS et al (2010) The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J 29:2082-2096
26. Wek RC, Jiang HY, Anthony TG (2006) Coping with stress: eIF2 kinases and translational control. Biochem Soc Trans 34:7-11 (Pubitemid 43235522)
27. Blais JD, Addison CL, Edge R et al (2006) Perkdependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress. Mol Cell Biol 26:9517-9532 (Pubitemid 44904443)
28. Richards NG, Kilberg MS (2006) Asparagine synthetase chemotherapy. Annu Rev Biochem 75:629-654 (Pubitemid 44118046)
29. Feng R, Zhai WL, Yang HY et al (2011) Induction of ER stress protects gastric cancer cells against apoptosis induced by cisplatin and doxorubicin through activation of p38 MAPK. Biochem Biophys Res Commun 406:299-304